|
|
 |
|
Viewing report
|
|
|
|
Aeolus Pharmaceuticals, Inc. (AOLS) - Financial and Strategic SWOT Analysis Review
GlobalData, June 2011, Pages: 40
Aeolus Pharmaceuticals, Inc. (AOLS) - Financial and Strategic SWOT Analysis Review
Summary
Aeolus Pharmaceuticals Inc. (Aeolus) is a biopharmaceutical company engaged in developing a new class of catalytic antioxidant compounds with the help of technology at Duke University and National Jewish Health. These compounds are used for disease and disorders of the central nervous system, respiratory system, autoimmune system and oncology. It is focusing on the side effects of mustard gas exposure, cancer radiation therapy, epilepsy and Parkinson’s disease. The lead product candidate of the company is AEOL 10150, along with the other products,AEOL 11207. Aeolus received funding from the Michael J. Fox Foundation to further test AEOL 11207 and several other compounds. The company is headquartered in California, the US.
Aeolus Pharmaceuticals, Inc. Key Recent Developments…
May 16, 2011 Aeolus Pharmaceuticals Reports Net Income Of $3.4m For Q2 Fiscal 2011
Feb 15, 2011 Aeolus Pharmaceuticals Appoints Russell Skibsted As Senior Vice President And CFO
Feb 15, 2011 Aeolus Pharmaceuticals Receives $118m From BARDA To Develop Treatment For Lung Acute Radiation Syndrome
Feb 15, 2011 BARDA Awards Two Drug Development Contracts For Protection Against Radiation
Feb 11, 2011 Aeolus Pharmaceuticals Reports Net Loss Of $7.6m For Q1 Fiscal 2011
This comprehensive SWOT profile of Aeolus Pharmaceuticals, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Elite Pharmaceuticals, Inc. (ELTP) - Financial and Strategic SWOT Analysis Review
Derma Sciences, Inc. (DSCI) - Financial and Strategic SWOT Analysis Review
Thallion Pharmaceuticals Inc. (TLN) - Financial and Strategic SWOT Analysis Review
Ono Pharmaceutical Co., Ltd. (4528) - Financial and Strategic SWOT Analysis Review
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review
Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review
Momenta Pharmaceuticals, Inc. (MNTA) - Financial and Strategic SWOT Analysis Review
Alexion Pharmaceuticals, Inc. (ALXN) - Financial and Strategic SWOT Analysis Review
Isis Pharmaceuticals, Inc. (ISIS) - Financial and Strategic SWOT Analysis Review
MAP Pharmaceuticals, Inc. (MAPP) - Financial and Strategic SWOT Analysis Review
|
|
|
|
